- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
Probiodrug reports new strategy for treating Alzheimer’s disease
Sunday 11 September 2011
Privately-held Probiodrug AG of Germany has put forward a strategy for treating Alzheimer’s disease that involves inhibiting an enzyme called glutaminyl cyclase, which is thought to play a role in the deposition of toxic amyloid plaques in the brain.
Location
Germany
Roche investigates drug for Down syndrome
Friday 9 September 2011
The Roche group has announced the start of a Phase 1 clinical study of a new molecule designed to address the cognitive and behavioural deficits associated with Down syndrome. The drug targets the GABAergic system.
Location
Switzerland
GSK stops one arm of lapatinib trial
Friday 9 September 2011
GlaxoSmithKline Plc has stopped one arm of a four-arm study in which its tyrosine kinase inhibitor, lapatinib (Tykerb/Tyverb), is being investigated as an adjuvant therapy for women with HER2 positive early-stage breast cancer.
Location
United Kingdom
4SC says HDAC inhibitor meets primary endpoint
Tuesday 6 September 2011
4SC AG of Germany has reported that its lead cancer drug, resminostat, has met its primary endpoint in a Phase 2 trial of patients with refractory Hodgkin’s Lymphoma who had been heavily treated with other therapies prior to the trial.
Location
Germany
Noxxon starts new trial of oligonucleotide
Tuesday 6 September 2011
Noxxon Pharma AG has started a Phase 1 study of an oligonucleotide-based drug to treat patients who suffer anaemia from chronic disease. The drug targets the peptide hormone, hepcidin, a regulator of iron metabolism.
Location
Germany
Metformin used to starve cancer cells
Thursday 1 September 2011
Scientists from Cancer Research UK have discovered that they could kill bowel cancer cells in the laboratory by targeting a protein complex that regulates energy generation in the cell.
Location
United Kingdom
Role of JAK in cancer migration described
Saturday 20 August 2011
A team of European scientists has described how a member of the Janus kinase (JAK) family of proteins generates contractions in tumours thereby allowing cancer cells to migrate from their site of origin. The findings were published in the journal, Cancer Cell, on 16 August.
Location
United Kingdom
Researchers isolate antibodies against HIV
Friday 19 August 2011
A team of international researchers has isolated 17 new broadly neutralising antibodies that may be effective against many variants of HIV, the virus that causes AIDS. The finding appeared online in Nature on 17 August.
Location
United States
Exon skipping shows promise for Duchenne muscular dystrophy
Friday 19 August 2011
An RNA-based therapeutic developed by AVI BioPharma Inc of the US has shown promise as a disease-modifying treatment for patients with Duchenne muscular dystrophy, a fatal genetic disorder, according to an article in The Lancet.
Location
United Kingdom
Transgene reports on oncolytic virus therapy
Tuesday 2 August 2011
Transgene SA said that its in-licensed oncolytic virus therapy, JX-594, has shown a “mechanistic proof-of-concept” in an early clinical trial of patients with metastatic melanoma. The results of the trial have been reported in Molecular Therapy.
Location
France
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013